Stoke Therapeutics, Inc. STOK Change in AR
Change in AR at other companies
Other financials
Where this comes from
Reported directly by Stoke Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsReceivable.
The official record: Stoke Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Stoke Therapeutics, Inc.'s change in ar.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Stoke Therapeutics, Inc.'s change in AR?
- Stoke Therapeutics, Inc. (STOK) reported change in AR of -$1.49M in Q1 2026.
- How has Stoke Therapeutics, Inc.'s change in AR changed year-over-year?
- Stoke Therapeutics, Inc.'s change in AR decreased by 212.2% year-over-year, from $1.33M to -$1.49M.
- What does change in AR mean?
- Increase or decrease in amounts owed by customers — the primary working capital driver for many businesses.